DOCSLIB.ORG

Lipoyl Moieties in the Pyruvate and A-Ketoglutarate Dehydrogenase

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lipoyl Moieties in the Pyruvate and A-Ketoglutarate Dehydrogenase Vol. 74, No. 10, pp 42&S-4227, October 1977 Biochemistry Acyl group and electron pair relay system: A network of interacting lipoyl moieties in the pyruvate and a-ketoglutarate dehydrogenase complexes from Escherichia coli (multienzyme complexes/thiol-disulfide interchange/crosslinking of subunits) JIMMY H. COLLINS AND LESTER J. REED Clayton Foundation Biochemical Institute and Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712 Contributed by Lester J. Reed, August 18, 1977 ABSTRACT The dihydrolipoyl transacetylase component complex by [2-'4C]pyruvate (6) and of the pyruvate-dependent of the Escherichia coli pyruvate dehydrogenase complex [pyr- reaction of N-ethyl[2,3-14C]maleimide with the complex (7) uvate:lipoate oxidoreductase (decarboxylating and acceptor- indicate the presence of two functionally active lipoyl acetylating), EC 1.2.4.11 bears two sites on each of its 24poly- moieties peptide chains that undergo reductive acetylation by on each transacetylase chain. 2-4C pyruvate and thiamin pyrophosphate, acetylation by In this communication, we confirm and extend this latter [lMClacetyl-CoA in the presence of DPNH, and reaction with finding, and we present evidence indicating that the trans- N-ethyl[2,3-14Clmaleimide in the presence of pyruvate and succinylase component of the a-ketoglutarate dehydrogenase thiamin pyrophosphate. The data strongly ir tat these sites complex bears one functionally active lipoyl moiety per chain are covalent y bound lipoyl moieties. The results of similar ex- and that the 48 lipoyl moieties in periments with the E. coli a-ketoglutarate dehydrogenase the transacetylase and the 24 complex [2-oxoglutaratelipoate oxidoreductase (decarboxylating lipoyl moieties in the transsuccinylase comprise a network that and acceptor-succinylating), EC 1±2.4.2] indicate that its dihy- functions as an acyl group and electron pair relay system drolipoyl transsuccinylase component bears only one lipoyl through thiol-disulfide and acyl-transfer reactions among all moiety on each of its 24 chains. Chagng of the 48 acetyl ac- of the lipoyl moieties. ceptor sites on the transacetylase or the 24 succinyl acceptor sites on the transsuccinylase by pyruvate or cc-ketoglutarate, re- spectively, and thiamin pyrophosphate was observed in the MATERIALS AND METHODS presence. of only a few functionally active pyruvate dehydro- The specific activities of the pyruvate and a-ketoglutarate genase or a-ketoglutarate dehydro enase chains. Extensive dehydrogenase complexes were 40-49 and 30-35 ,mol of crosslinking of the transacetylase chains was observed when DPNH per min/mg of protein, respectively (8, 9). The ra- the pyruvate dehydrogenase complex was treated with pyruvate dioactive componltds were obtained from Amersham/Searle, and thiamin pyrophosphate or with DPNH in the presence of N,N'-o- or N,N-p-phenylenedimaleimide, respectively. When and N,N'-o- and NN'-p-phenylenedimaleimides (o-PDM and the a-ketoglutarate dehydrogenase complex was treated with p-PDM) were from Aldrich. Thiamin thiazolone pyrophosphate DPNH in the presence of NN-p-phenylenedimaleimide, only was prepared as described by Butler et al. (10). transsuccinylase monomers and crosslinked transsuccinylase The specific radioactivities of the "4C-labeled compounds dimers were detected. It appears that the 48 lipoyl moieties in were determined as follows. The concentrations of stock solu- the transacetylase and the 24 lipoyl moieties in the transsuc- tions of [2-14C]pyruvate and a-[5-14C]ketoglutarate were cinylase comprise an interacting network that functions as an acyl group and electron pair relay system through thioldisulfide measured spectrophotometrically as DPNH produced by oxi- and acyl-transfer reactions among all of the lipoyl moieties. dative decarboxylation in the presence of the pyruvate or a- ketoglutarate dehydrogenase complex (9). Samples of known The pyruvate dehydrogenase complex [pyruvate:lipoate oxi- 14C content were diluted with an accurately measured amount doreductase (decarboxylating and acceptor-acetylating), EC of pure pyruvate or a-ketoglutarate and converted to the 1.2.4.1] and the a-ketoglutarate dehydrogenase complex [2- semicarbazone, and the derivative was recrystallized to constant oxoglutarate:lipoate (decarboxylating and acceptor-succinyl- specific radioactivity. The concentration of N-ethyl[2,3- ating), EC 1.2.4.2] from Escherichia coil each consists of three 14C]maleimide was determined spectrophotometrically (11). enzymes that, acting in sequence, catalyze the reactions shown A sample of known 14C content was diluted with pure N-eth- in Fig. 1. Each complex is organized about a core consisting of ylmaleimide and converted to S-(N-ethylsuccinimido)-L-cys- dihydrolipoyl transacetylase or dihydrolipoyl transsuccinylase teine (12), and the derivative was recrystallized to constant to which the other two enzymes (pyruvate dehydrogenase or specific radioactivity. The results of this method were in good a-ketoglutarate dehydrogenase and dihydrolipoyl dehydro- agreement with the specific radioactivity determined by genase) are joined by noncovalent bonds (1). The transacetylase analysis of the S-[(1,2-dicarboxy)ethyl] cysteine derivative (7) and transsuccinylase each consists of 24 apparently identical on a Beckman 120C amino acid analyzer equipped with an polypeptide chains in an arrangement having octahedral in-line scintillation counter. [1-"4C]Acetyl-CoA was diluted 1:10 symmetry (2). The cofactor lipoic acid is covalently attached with nonradioactive acetyl-CoA, and the concentration was by an amide bond to a lysine residue in the two transacylases. determined spectrophotometrically with phosphotransacetylase The lipoyl moiety is thought to rotate among the catalytic and arsenate (13). Measurement of protein-bound radioactivity centers of the three enzymes in each complex (3). Studies of the and performic acid-labile acyl groups on filter paper disks was mobility of the spin-labeled lipoyl moieties in the pyruvate carried out as described by Pettit et al. (9). Radioactivity was dehydrogenase complex are consistent with this view (4, 5). determined in a Beckman LS-230 scintillation counter with Studies of the acetylation of the pyruvate dehydrogenase ACS cocktail (Amersham/Searle). The costs of publication of this article were defrayed in part by the Abbreviations: o-PDM, N,N'-o-phenylenedimaleimide; p-PDM, payment-of page charges. This article must therefore be hereby marked N,N'-p-phenylenedimaleimide; NaDodSO4, sodium dodecyl sulfate; "adcement" in accordance with 18 U.S.C. §1734 solely to indicate Mr. molecular weight. this fact. 4223 Downloaded by guest on September 28, 2021 4224 Biochemistry: Collins and Reed Proc. Natl. Acad. Sci. USA 74 (1977) Table 1. Stoichiometry of substrate-dependent incorporation of DPN* acyl groups and N-ethylmaleimide 5 [14C]acyl groups [14C]NEM OH [H DPNH + Ht incorporated, incorporated, [RCH-TPP] [Lps2] dehydrogenase Additions mol/mol complex mol/mol complex Co2 [FAD] dehydrogenasePyruvate Dihydrolipoyl SS Pyruvate dehydrogenase complex 1 and 2 tronsocetylase [Lip(SH) ] II o~~~-Ke togluaote trnussuccinylasean RC-SCoA ['4C]Pyruvate 47.8 4 1.4 (11) RCC02H dehydrogenase 0 ['4C]Pyruvate + NEM 49.6 4 1.4 (8) [RC-SLipSH] Pyruvate + [14C]NEM 51.1 + 1.9 (4) [TPP] [14C]NEM 5.7 + 0.9 (3) 0 O CoASH a-Ketoglutarate dehydrogenase complex RCCO2H + CoASH + DPN+ -4- RC-'SCoA t CO2 + DPNH + HR 23.3 I 0.6 (3) FIG. 1. Reaction sequence in pyruvate and a-ketoglutarate oxi- [14C]KG dation. TPP, thiamin pyrophosphate; LipS2 and Lip(SH)2, lipoyl [14C]KG + NEM 24.4 + 0.5 (3) moiety and its reduced form. KG + [14C]NEM 26.3 + 1.1 (3) [14C]NEM 3.8 I 0.7 (2) protein-bound acetyl groups were stabilized in the presence of Pyruvate dehydrogenase complex (PDC) or a-ketoglutarate de- N-ethylmaleimide. In parallel experiments, treatment of the hydrogenase complex (KGDC) at 1.0 to 2.0 mg/ml was treated at 40 native complex with N-ethyl[2,3-14C]maleimide in the presence under N2 with 0.25 mM [2-14C]pyruvate or a-[5-14C]ketoglutarate of nonradioactive pyruvate and thiamin pyrophosphate resulted (KG), respectively, in the presence and absence of 0.5 mM nonra- dioactive N-ethylmaleimide (NEM), and with 0.5 mM N-ethyl[2,3- in incorporation of about 51 mol of the radioactive maleimide 14C~maleimide in the presence and absence of0.25 mM nonradioactive per mol of complex. In the absence of pyruvate about 6 mol of pyruvate or a-ketoglutarate in 50 mM potassium phosphate buffer the maleimide were incorporated. These data demonstrate the (pH 7.0) containing 0.2 mM thiamin pyrophosphate, 1 mM MgCl2, incorporation of about 45 mol of the radioactive maleimide per and 1 mM EDTA. Incorporation of [14C]acetyl or [l4C]succinyl groups mol of complex in a pyruvate-dependent reaction. The py- was determined after 1 min incubation by the filter paper disk pro- ruvate-dependent incorporation of N-ethyl[2,3-14C]maleimide cedure described in Materials and Methods. Incorporation of CoA (0.1 mM) and [14C]NEM was determined on aliquots of the incubation mixtures that was inhibited at least 95% by addition of had been quenched with 5 mM 2-mercaptoethanol after the overall arsenite (1 mM) 20 min prior to addition of the maleimide. This activity of the complex had decreased to less than 5% of the original observation provides further evidence for the selective modi- activity [about 15 min (4, 16)]. Activity losses due to incubation with fication of the lipoyl moieties by N-ethylmaleimide, because pyruvate or a-ketoglutarate or NEM individually were less than 10%. arsenite is known to react with the dithiol form of lipoic acid Results are means I SD; the number of determinations is given in (17). When the pyruvate dehydrogenase complex was treated parentheses. with both [2-'4C]pyruvate and N-ethyl[2,3-14C]maleimide in the presence of thiamin pyrophosphate, the amount of radio- Sodium dodecyl sulfate (NaDodSO4)/polyacrylamide gel activity incorporated into the complex corresponded closely electrophoresis was carried out in 4% or 5% (wt/vol) gels as to the sum of the radioactivities incorporated in parallel ex- described by Weber and Osborn (14).
Load more

Recommended publications
  • Supplement 1 Overview of Dystonia Genes
    Supplement 1 Overview of genes that may cause dystonia in children and adolescents Gene (OMIM) Disease name/phenotype Mode of inheritance 1: (Formerly called) Primary dystonias (DYTs): TOR1A (605204) DYT1: Early-onset generalized AD primary torsion dystonia (PTD) TUBB4A (602662) DYT4: Whispering dystonia AD GCH1 (600225) DYT5: GTP-cyclohydrolase 1 AD deficiency THAP1 (609520) DYT6: Adolescent onset torsion AD dystonia, mixed type PNKD/MR1 (609023) DYT8: Paroxysmal non- AD kinesigenic dyskinesia SLC2A1 (138140) DYT9/18: Paroxysmal choreoathetosis with episodic AD ataxia and spasticity/GLUT1 deficiency syndrome-1 PRRT2 (614386) DYT10: Paroxysmal kinesigenic AD dyskinesia SGCE (604149) DYT11: Myoclonus-dystonia AD ATP1A3 (182350) DYT12: Rapid-onset dystonia AD parkinsonism PRKRA (603424) DYT16: Young-onset dystonia AR parkinsonism ANO3 (610110) DYT24: Primary focal dystonia AD GNAL (139312) DYT25: Primary torsion dystonia AD 2: Inborn errors of metabolism: GCDH (608801) Glutaric aciduria type 1 AR PCCA (232000) Propionic aciduria AR PCCB (232050) Propionic aciduria AR MUT (609058) Methylmalonic aciduria AR MMAA (607481) Cobalamin A deficiency AR MMAB (607568) Cobalamin B deficiency AR MMACHC (609831) Cobalamin C deficiency AR C2orf25 (611935) Cobalamin D deficiency AR MTRR (602568) Cobalamin E deficiency AR LMBRD1 (612625) Cobalamin F deficiency AR MTR (156570) Cobalamin G deficiency AR CBS (613381) Homocysteinuria AR PCBD (126090) Hyperphelaninemia variant D AR TH (191290) Tyrosine hydroxylase deficiency AR SPR (182125) Sepiaterine reductase
    [Show full text]
  • 1 Silencing Branched-Chain Ketoacid Dehydrogenase Or
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.960153; this version posted February 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Silencing branched-chain ketoacid dehydrogenase or treatment with branched-chain ketoacids ex vivo inhibits muscle insulin signaling Running title: BCKAs impair insulin signaling Dipsikha Biswas1, PhD, Khoi T. Dao1, BSc, Angella Mercer1, BSc, Andrew Cowie1 , BSc, Luke Duffley1, BSc, Yassine El Hiani2, PhD, Petra C. Kienesberger1, PhD, Thomas Pulinilkunnil1†, PhD 1Department of Biochemistry and Molecular Biology, Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada, 2Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada. †Correspondence to Thomas Pulinilkunnil, PhD Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University Dalhousie Medicine New Brunswick, 100 Tucker Park Road, Saint John E2L4L5, New Brunswick, Canada. Telephone: (506) 636-6973; Fax: (506) 636-6001; email: [email protected]. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.960153; this version posted February 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International
    [Show full text]
  • Transglutaminase-Catalyzed Inactivation Of
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 12604–12609, November 1997 Medical Sciences Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and a-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length ARTHUR J. L. COOPER*†‡§, K.-F. REX SHEU†‡,JAMES R. BURKE¶i,OSAMU ONODERA¶i, WARREN J. STRITTMATTER¶i,**, ALLEN D. ROSES¶i,**, AND JOHN P. BLASS†‡,†† Departments of *Biochemistry, †Neurology and Neuroscience, and ††Medicine, Cornell University Medical College, New York, NY 10021; ‡Burke Medical Research Institute, Cornell University Medical College, White Plains, NY 10605; and Departments of ¶Medicine, **Neurobiology, and iDeane Laboratory, Duke University Medical Center, Durham, NC 27710 Edited by Louis Sokoloff, National Institutes of Health, Bethesda, MD, and approved August 28, 1997 (received for review April 24, 1997) ABSTRACT Several adult-onset neurodegenerative dis- Q12-containing peptide (16). In the work of Kahlem et al. (16) the eases are caused by genes with expanded CAG triplet repeats largest Qn domain studied was Q18. We found that both a within their coding regions and extended polyglutamine (Qn) nonpathological-length Qn domain (n 5 10) and a longer, patho- domains within the expressed proteins. Generally, in clinically logical-length Qn domain (n 5 62) are excellent substrates of affected individuals n > 40. Glyceraldehyde 3-phosphate dehy- tTGase (17, 18). drogenase binds tightly to four Qn disease proteins, but the Burke et al. (1) showed that huntingtin, huntingtin-derived significance of this interaction is unknown. We now report that fragments, and the dentatorubralpallidoluysian atrophy protein purified glyceraldehyde 3-phosphate dehydrogenase is inacti- bind selectively to glyceraldehyde 3-phosphate dehydrogenase vated by tissue transglutaminase in the presence of glutathione (GAPDH) in human brain homogenates and to immobilized S-transferase constructs containing a Qn domain of pathological rabbit muscle GAPDH.
    [Show full text]
  • 1 Silencing Branched-Chain Ketoacid Dehydrogenase Or
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.960153; this version posted February 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Silencing branched-chain ketoacid dehydrogenase or treatment with branched-chain ketoacids ex vivo inhibits muscle insulin signaling Running title: BCKAs impair insulin signaling Dipsikha Biswas1, PhD, Khoi T. Dao1, BSc, Angella Mercer1, BSc, Andrew Cowie1 , BSc, Luke Duffley1, BSc, Yassine El Hiani2, PhD, Petra C. Kienesberger1, PhD, Thomas Pulinilkunnil1†, PhD 1Department of Biochemistry and Molecular Biology, Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada, 2Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada. †Correspondence to Thomas Pulinilkunnil, PhD Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University Dalhousie Medicine New Brunswick, 100 Tucker Park Road, Saint John E2L4L5, New Brunswick, Canada. Telephone: (506) 636-6973; Fax: (506) 636-6001; email: [email protected]. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.960153; this version posted February 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International
    [Show full text]
  • Aerobic Glycolysis Fuels Platelet Activation: Small-Molecule Modulators of Platelet Metabolism As Anti-Thrombotic Agents
    ARTICLE Platelet Biology & its Disorders Aerobic glycolysis fuels platelet activation: Ferrata Storti Foundation small-molecule modulators of platelet metabolism as anti-thrombotic agents Paresh P. Kulkarni,1† Arundhati Tiwari,1† Nitesh Singh,1 Deepa Gautam,1 Vijay K. Sonkar,1 Vikas Agarwal2 and Debabrata Dash1 1Department of Biochemistry, Institute of Medical Sciences and 2Department of Cardiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Haematologica 2019 Pradesh, India Volume 104(4):806-818 † PPK and AT contributed equally to this work. ABSTRACT latelets are critical to arterial thrombosis, which underlies myocardial infarction and stroke. Activated platelets, regardless of the nature of Ptheir stimulus, initiate energy-intensive processesthat sustain throm- bus, while adapting to potential adversities of hypoxia and nutrient depri- vation within the densely packed thrombotic milieu. We report here that stimulated platelets switch their energy metabolism to robicae glycolysis by modulating enzymes at key checkpoints in glucose metabolism. We found that aerobic glycolysis, in turn, accelerates flux through the pentose phos- phate pathway and supports platelet activation. Hence, reversing metabolic adaptations of platelets could be an effective alternative to conventional anti-platelet approaches, which are crippled by remarkable redundancy in platelet agonists and ensuing signaling pathways. In support of this hypoth- esis, small-molecule modulators of pyruvate dehydrogenase, pyruvate kinase M2 and glucose-6-phosphate dehydrogenase, all of which impede aerobic glycolysis and/or the pentose phosphate pathway, restrained the Correspondence: agonist-induced platelet responsesex vivo. These drugs, which include the DEBABRATA DASH anti-neoplastic candidate, dichloroacetate, and the Food and Drug [email protected] Administration-approved dehydroepiandrosterone, profoundly impaired thrombosis in mice, thereby exhibiting potential as anti-thrombotic agents.
    [Show full text]
  • Emerging Roles of P53 Family Members in Glucose Metabolism
    International Journal of Molecular Sciences Review Emerging Roles of p53 Family Members in Glucose Metabolism Yoko Itahana and Koji Itahana * Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore; [email protected] * Correspondence: [email protected]; Tel.: +65-6516-2554; Fax: +65-6221-2402 Received: 19 January 2018; Accepted: 22 February 2018; Published: 8 March 2018 Abstract: Glucose is the key source for most organisms to provide energy, as well as the key source for metabolites to generate building blocks in cells. The deregulation of glucose homeostasis occurs in various diseases, including the enhanced aerobic glycolysis that is observed in cancers, and insulin resistance in diabetes. Although p53 is thought to suppress tumorigenesis primarily by inducing cell cycle arrest, apoptosis, and senescence in response to stress, the non-canonical functions of p53 in cellular energy homeostasis and metabolism are also emerging as critical factors for tumor suppression. Increasing evidence suggests that p53 plays a significant role in regulating glucose homeostasis. Furthermore, the p53 family members p63 and p73, as well as gain-of-function p53 mutants, are also involved in glucose metabolism. Indeed, how this protein family regulates cellular energy levels is complicated and difficult to disentangle. This review discusses the roles of the p53 family in multiple metabolic processes, such as glycolysis, gluconeogenesis, aerobic respiration, and autophagy. We also discuss how the dysregulation of the p53 family in these processes leads to diseases such as cancer and diabetes. Elucidating the complexities of the p53 family members in glucose homeostasis will improve our understanding of these diseases.
    [Show full text]
  • Glycolysis Citric Acid Cycle Oxidative Phosphorylation Calvin Cycle Light
    Stage 3: RuBP regeneration Glycolysis Ribulose 5- Light-Dependent Reaction (Cytosol) phosphate 3 ATP + C6H12O6 + 2 NAD + 2 ADP + 2 Pi 3 ADP + 3 Pi + + 1 GA3P 6 NADP + H Pi NADPH + ADP + Pi ATP 2 C3H4O3 + 2 NADH + 2 H + 2 ATP + 2 H2O 3 CO2 Stage 1: ATP investment ½ glucose + + Glucose 2 H2O 4H + O2 2H Ferredoxin ATP Glyceraldehyde 3- Ribulose 1,5- Light Light Fx iron-sulfur Sakai-Kawada, F Hexokinase phosphate bisphosphate - 4e + center 2016 ADP Calvin Cycle 2H Stroma Mn-Ca cluster + 6 NADP + Light-Independent Reaction Phylloquinone Glucose 6-phosphate + 6 H + 6 Pi Thylakoid Tyr (Stroma) z Fe-S Cyt f Stage 1: carbon membrane Phosphoglucose 6 NADPH P680 P680* PQH fixation 2 Plastocyanin P700 P700* D-(+)-Glucose isomerase Cyt b6 1,3- Pheophytin PQA PQB Fructose 6-phosphate Bisphosphoglycerate ATP Lumen Phosphofructokinase-1 3-Phosphoglycerate ADP Photosystem II P680 2H+ Photosystem I P700 Stage 2: 3-PGA Photosynthesis Fructose 1,6-bisphosphate reduction 2H+ 6 ADP 6 ATP 6 CO2 + 6 H2O C6H12O6 + 6 O2 H+ + 6 Pi Cytochrome b6f Aldolase Plastoquinol-plastocyanin ATP synthase NADH reductase Triose phosphate + + + CO2 + H NAD + CoA-SH isomerase α-Ketoglutarate + Stage 2: 6-carbonTwo 3- NAD+ NADH + H + CO2 Glyceraldehyde 3-phosphate Dihydroxyacetone phosphate carbons Isocitrate α-Ketoglutarate dehydogenase dehydrogenase Glyceraldehyde + Pi + NAD Isocitrate complex 3-phosphate Succinyl CoA Oxidative Phosphorylation dehydrogenase NADH + H+ Electron Transport Chain GDP + Pi 1,3-Bisphosphoglycerate H+ Succinyl CoA GTP + CoA-SH Aconitase synthetase
    [Show full text]
  • Dynamic Control Over Feedback Regulation Identifies Pyruvate-Ferredoxin Oxidoreductase As a Central Metabolic Enzyme in Stationary Phase E
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.26.219949; this version posted August 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dynamic control over feedback regulation identifies pyruvate-ferredoxin oxidoreductase as a central metabolic enzyme in stationary phase E. coli. ​ 1,* 2,* 2 2 2,3, + Shuai Li ,​ Zhixia Ye ,​ Juliana Lebeau ,​ Eirik A. Moreb ,and​ Michael D. Lynch 1 ​ ​ ​ ​ ​ Department​ of Chemistry, Duke University 2 Department​ of Biomedical Engineering, Duke University *Authors contributed equally to this work. 3 To​ whom all correspondence should be addressed. [email protected] Abstract: We demonstrate the use of two-stage dynamic metabolic control to manipulate ​ feedback regulation in central metabolism and improve stationary phase biosynthesis in engineered E. coli. Specifically, we report the impact of dynamic control over two enzymes: ​ citrate synthase, and glucose-6-phosphate dehydrogenase, on stationary phase fluxes. Firstly, ​ ​ ​ ​ reduced citrate synthase levels lead to a reduction in 휶-ketoglutarate, which is an inhibitor of sugar transport, resulting in increased stationary phase glucose uptake and glycolytic fluxes. Reduced glucose-6-phosphate dehydrogenase activity activates the SoxRS regulon and expression of pyruvate-ferredoxin oxidoreductase, which is in turn responsible for large increases in acetyl-CoA production. The combined reduction in citrate synthase and glucose-6-phosphate dehydrogenase, leads to greatly enhanced stationary phase metabolism and ​ the improved production of citramalic acid enabling titers of 126±7g/L. These results identify pyruvate oxidation via the pyruvate-ferredoxin oxidoreductase as a “central” metabolic pathway in stationary phase E.
    [Show full text]
  • The Spectrum of Pyruvate Dehydrogenase Complex Deficiency
    Molecular Genetics and Metabolism 105 (2012) 34–43 Contents lists available at SciVerse ScienceDirect Molecular Genetics and Metabolism journal homepage: www.elsevier.com/locate/ymgme Minireview The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical and genetic features in 371 patients Kavi P. Patel a, Thomas W. O'Brien b, Sankarasubramon H. Subramony c, Jonathan Shuster d, Peter W. Stacpoole a,b,⁎ a Departments of Medicine (Division of Endocrinology and Metabolism), College of Medicine, University of Florida, Gainesville, FL 32611, USA b Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32611, USA c Neurology, College of Medicine, University of Florida, Gainesville, FL 32611, USA d Epidemiology and Health Policy Research, College of Medicine, University of Florida, Gainesville, FL 32611, USA article info abstract Article history: Context: Pyruvate dehydrogenase complex (PDC) deficiency is a genetic mitochondrial disorder commonly Received 2 September 2011 associated with lactic acidosis, progressive neurological and neuromuscular degeneration and, usually, Received in revised form 27 September 2011 death during childhood. There has been no recent comprehensive analysis of the natural history and clinical Accepted 27 September 2011 course of this disease. Available online 7 October 2011 Objective: We reviewed 371 cases of PDC deficiency, published between 1970 and 2010, that involved defects in subunits E1α and E1β and components E1, E2, E3 and the E3 binding protein of the complex. Keywords: Data sources and extraction: English language peer-reviewed publications were identified, primarily by using Congenital lactic acidosis Dichloroacetate PubMed and Google Scholar search engines. Neuroimaging Results: Neurodevelopmental delay and hypotonia were the commonest clinical signs of PDC deficiency.
    [Show full text]
  • Paroxysmal Spasticity of Lower Extremities As the Initial Symptom in Two Siblings with Maple Syrup Urine Disease
    4872 MOLECULAR MEDICINE REPORTS 19: 4872-4880, 2019 Paroxysmal spasticity of lower extremities as the initial symptom in two siblings with maple syrup urine disease YI-DAN LIU1*, XU CHU2*, RUI-HUA LIU3, YING SUN1, QING-XIA KONG2 and QIU-BO LI3 1Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012; Departments of 2Neurology and 3Pediatrics, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China Received July 31, 2018; Accepted April 1, 2019 DOI: 10.3892/mmr.2019.10133 Abstract. Maple syrup urine disease (MSUD) is a rare heterozygous mutations in the BCKDHB gene found in the autosomal recessive metabolic disorder caused by muta- Chinese family may be responsible for the phenotype of the tions in genes that encode subunits of the branched-chain two siblings with MSUD. α-ketoacid dehydrogenase (BCKD) complex. Impairment of the BCKD complex results in an abnormal accumulation Introduction of branched-chain amino acids and their corresponding branched‑chain keto acids in the blood and cerebrospinal fluid, In the wide array of inherited metabolic disorders, maple which are neurovirulent and may become life-threatening. An syrup urine disease (MSUD; Online Mendelian Inheritance 11-day-old boy was admitted to the hospital with paroxysmal in Man no. 248600; https://www.omim.org/entry/248600) has spasticity of lower extremities. Of note, his 10-year-old sister attracted increasing attention due to the potential neurological presented similar symptoms during the neonatal period, and damage caused by this disorder (1). MSUD was first reported her condition was diagnosed as MSUD when she was 1.5 years by Menkes et al (2) in 1954.
    [Show full text]
  • 1,2,3,5,6,8,10,11,16,20,21 Citric Acid Cycle Reactions
    Overview of the citric acid cycle, AKA the krebs cycle AKA tricarboxylic acid AKA TCA cycle Suggested problems from the end of chapter 19: 1,2,3,5,6,8,10,11,16,20,21 Glycogen is broken down into glucose. The reactions of glycolysis result in pyruvate, which is then fed into the citric acid cycle in the form of acetyl CoA. The products of the citric acid cycles are 2 CO2, 3 NADH, 1 FADH2, and 1 ATP or GTP. After pyruvate is generated, it is transported into the mitochondrion, an organelle that contains the citric acid cycle enzymes and the oxidative phosphorylation enzymes. In E. coli, where there are neither mitochondria nor other organelles, these enzymes also seem to be concentrated in certain regions in the cell. Citric acid cycle reactions Overall, there are 8 reactions that result in oxidation of the metabolic fuel. This results in reduction of NAD+ and FAD. NADH and FADH2 will transfer their electrons to oxygen during oxidative phosphorylation. •In 1936 Carl Martius and Franz Knoop showed that citrate can be formed non-enzymaticly from Oxaloacetate and pyruvate. •In 1937 Hans Krebs used this information for biochemical experiments that resulted in his suggestion that citrate is processed in an ongoing circle, into which pyruvate is “fed.” •In 1951 it was shown that it was acetyl Coenzyme-A that condenses with oxaloacetate to form citrate. 1 The pre-citric acid reaction- pyruvate dehydrogenase Pyruvate dehydrogenase is a multi-subunit complex, containing three enzymes that associate non-covalently and catalyze 5 reaction. The enzymes are: (E1) pyruvate dehydrogenase (E2) dihydrolipoyl transacetylase (E3) dihydrolipoyl dehydrogenase What are the advantages for arranging enzymes in complexes? E.
    [Show full text]
  • Mitochondrial Calcium Regulation of Redox Signaling in Cancer
    cells Review Mitochondrial Calcium Regulation of Redox Signaling in Cancer 1, 2, 3 2 Céline Delierneux y , Sana Kouba y, Santhanam Shanmughapriya , Marie Potier-Cartereau , Mohamed Trebak 1 and Nadine Hempel 1,4,* 1 Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA 17033, USA; [email protected] (C.D.); [email protected] (M.T.) 2 Inserm U1069 Nutrition, Croissance et Cancer, Université de Tours, 10 Boulevard Tonnellé, 37032 Tours, France; [email protected] (S.K.); [email protected] (M.P.-C.) 3 Department of Medicine, The Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA 17033, USA; [email protected] 4 Department of Pharmacology, and Obstetrics and Gynecology, The Pennsylvania State University College of Medicine, 500 University Dr., Hershey, PA 17033, USA * Correspondence: [email protected]; Tel.: +717-531-4037 These authors contributed equally to this work. y Received: 8 January 2020; Accepted: 10 February 2020; Published: 12 February 2020 Abstract: Calcium (Ca2+) uptake into the mitochondria shapes cellular Ca2+ signals and acts as a key effector for ATP generation. In addition, mitochondria-derived reactive oxygen species (mROS), produced as a consequence of ATP synthesis at the electron transport chain (ETC), modulate cellular signaling pathways that contribute to many cellular processes. Cancer cells modulate mitochondrial Ca2+ ([Ca2+]m) homeostasis by altering the expression and function of mitochondrial Ca2+ channels and transporters required for the uptake and extrusion of mitochondrial Ca2+. Regulated elevations in [Ca2+]m are required for the activity of several mitochondrial enzymes, and this in turn regulates metabolic flux, mitochondrial ETC function and mROS generation.
    [Show full text]